Skip to main navigation
Investor Relations
  • Home
  • About Us
    • Our Goal
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology Platform
    • Our Focus
    • The Challenge
    • Platform
  • Focus Areas
    • Pipeline
    • Osteoporosis
    • Hypoparathyroidism
  • Investors
    • Share Information
      • Share Chart
    • Email Alerts
    • Press Releases
    • SEC Filings
    • Investor Calendar
    • Corporate Governance
      • Board of Directors
      • Management
      • Committee Composition
    • Investor Resources
      • Investor FAQS
      • Document Request
      • Email Alerts
  • Press Releases
  • Contact Us
Menu
Investor Relations
  • Home
  • About Us
    • Our Goal
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology Platform
    • Our Focus
    • The Challenge
    • Platform
  • Focus Areas
    • Pipeline
    • Osteoporosis
    • Hypoparathyroidism
  • Investors
    • Share Information
      • Share Chart
    • Email Alerts
    • Press Releases
    • SEC Filings
    • Investor Calendar
    • Corporate Governance
      • Board of Directors
      • Management
      • Committee Composition
    • Investor Resources
      • Investor FAQS
      • Document Request
      • Email Alerts
  • Press Releases
  • Contact Us

Governance Documents

Scientific Advisory Committee Charter 180.7 KB
Code of Ethics 230.2 KB
Nominating and Governance Committee Charter 96.9 KB
Compensation Committee Charter 33.5 KB
Audit Committee Charter 78.9 KB
Email Alerts
Investor FAQs
Contact IR
Logo

Hadassah Bio Park, 5th Floor |
Jerusalem Israel 9112002

info@enterabio.com

About Us
Company Profile
Strategy
Management Team
Board of Directors
Technology
Overview
Pipeline
Hypoparathyroidism
Osteoporosis
Bone Healing
News and Events
News
Events
Footer Bottom Social

Folow Us

  • Facebook
  • Twitter
  • Linkedin
  • Instagram

© 2024 Entera Bio Ltd. Privacy Policy